Non-invasive Prenatal Testing Service Launched
Yourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.
Yourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.
Measuring reproductive health is becoming more exacting as medical technology advances. One of the newest ways is with cytogenetics analysis.
Sera Prognostics' blood-based test offers individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.
Researchers have developed a testing device that may help advance diagnosis and treatment of preterm birth.
Read MoreVeritas has created a new prenatal diagnostic test that can help identify fetal anomalies in at-risk pregnancies.
Read MoreResearchers have identified biological markers that could improve blood tests of pregnant women to detect risks of pregnancy complications earlier.
Read MoreBioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.Â
Read MoreSema4 Elements, a portfolio of information-driven genomic reproductive health solutions that enable providers to treat patients holistically, has launched.
Read MoreHalf of pregnant women who had a simple blood test to check their iron stores had low iron levels; one in four had severe iron deficiency.
Read MoreBioReference Laboratories, Inc. has acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche.
Read MoreAs part of the agreement, EchelonDx is providing expertise using its precise PrenatalDx technology to help enhance the data analysis and reporting capabilities for Cradle’s comprehensive fetal genetic analysis and health screening solutions.
Read MoreOffering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
Read MoreThe method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.
Read MoreThe new CPT PLA code will facilitate billing and payment for the PreTRM Test, the company’s proprietary proteomic blood test for measuring a woman’s risk of spontaneous preterm birth to enable timely intervention.
Read MoreThe PRIME study is designed to provide a blueprint for how healthcare can more effectively identify and manage high-risk pregnancies and reduce preterm birth.
Read MoreA new study outlines a role for pregnancy-associated plasma protein A in gestational diabetes, with potential as a diagnostic tool and therapeutic target.
Read MoreThis proprietary test is a multi-analyte protein biomarker assay which is designed to be run from a simple blood draw.
Read MoreA blood test commonly used to detect fetal genetic abnormalities can be modified to help predict complications associated with pregnancy before any symptoms develop, according to UCLA researchers and colleagues.
Read More